Monday, August 08, 2011 4:06:36 AM
Is it worth my looking into
Seriously, I don't know much but as far as I can tell Xiaflex's data in Dupuytren's contracture were good. I don't know the market size and why sales are weak. Phase IIb data in Peyronie’s were mixed, but I see that phase III design is different, so probably a better chance to show stat-sig improvement over placebo.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
